Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years - JSON Representation

Active as of 2022-05-28

Raw json | Download


{
  "resourceType" : "EvidenceVariable",
  "id" : "32143",
  "meta" : {
    "versionId" : "13",
    "lastUpdated" : "2023-12-06T21:24:16.455Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: EvidenceVariable</b><a name=\"32143\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource EvidenceVariable &quot;32143&quot; Version &quot;13&quot; Updated &quot;2023-12-06 21:24:16+0000&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-variable-definition.html\">VariableDefinition</a></p></div><p><b>EvidenceVariableDefinition</b>: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control</p><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/EvidenceVariable/32143</code></p><p><b>identifier</b>: FEvIR Object Identifier:\u00a032143</p><p><b>version</b>: 1.0.0-ballot</p><p><b>name</b>: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years</p><p><b>title</b>: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years</p><p><b>status</b>: active</p><p><b>date</b>: 2022-05-28 12:16:43+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href=\"http://www.hl7.org/Special/committees/dss\">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years</p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style=\"display: none\">*</td><td>cite-as</td><td>OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32143. Revised 2022-05-28. Available at: https://fevir.net/resources/EvidenceVariable/32143. Computable resource at: https://fevir.net/resources/EvidenceVariable/32143.</td></tr></table><p><b>actual</b>: true</p><p><b>handling</b>: dichotomous</p></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-definition",
      "valueCodeableReference" : {
        "reference" : {
          🔗 "reference" : "Group/172480",
          "type" : "Group",
          "display" : "OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control"
        }
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode" : "cds"
    }
  ],
  "url" : "https://fevir.net/resources/EvidenceVariable/32143",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "https://fevir.net",
      "value" : "32143",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "version" : "1.0.0-ballot",
  "name" : "OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years",
  "title" : "OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years",
  "status" : "active",
  "date" : "2022-05-28T12:16:43.370Z",
  "publisher" : "HL7 International / Clinical Decision Support",
  "contact" : [
    {
      "name" : "HL7 International / Clinical Decision Support",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description" : "The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years",
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "author" : [
    {
      "name" : "Brian S. Alper"
    }
  ],
  "relatedArtifact" : [
    {
      "type" : "cite-as",
      "citation" : "OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32143. Revised 2022-05-28. Available at: https://fevir.net/resources/EvidenceVariable/32143. Computable resource at: https://fevir.net/resources/EvidenceVariable/32143."
    }
  ],
  "actual" : true,
  "handling" : "dichotomous"
}